Parabolic Drugs has entered the dosage space with an aim to make Rs 150 crore by way of sales within 3-5 years, said director Vineet Gupta.
Vineet Gupta, director of Parabolic Drugs spoke to CNBC-TV18 about the latest with is company and the way ahead.
There are reports stating that Parabolic Drugs is in talks with Japanese firms for bulk supply deals. In an interview to CNBC-TV18, Vineet Gupta, director of Parabolic Drugs confirmed the same.
Parabolic Drugs recently announced its results for the fourth quarter and for the financial year that ended March 31, 2011. Vineet Gupta, director of the company, says he is hopeful that new expansions “will help contribute to further margin expansion.”
In an interview with CNBC-TV18’s Latha Venkatesh and Reema Tendulkar, Vineet Gupta, Director of Parabolic Drugs, spoke on their pact with a local company on manufacturing nutraceutical bulk drugs.
In an interview CNBC-TV18, Vineet Gupta, Director, Parabolic Drugs, speaks about the results and gives his outlook going forward.